Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 19/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.56 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.56 |
| ▸ | GSK3A | P49840 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8342890 | 0.94 | GSK3B (0.68) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A | |
| SCHEMBL13917304 | 0.94 | GSK3B (0.60) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A | |
| SCHEMBL8344282 | 0.93 | GSK3B (0.59) | GSK3B | |
| SCHEMBL13917305 | 0.91 | GSK3B (0.53) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A | |
| SCHEMBL13917302 | 0.90 | GSK3B (0.54) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A | |
| SCHEMBL13917301 | 0.90 | GSK3B (0.69) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A | |
| SCHEMBL13917292 | 0.89 | GSK3B (0.65) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A | |
| SCHEMBL13917303 | 0.88 | GSK3B (0.58) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A | |
| SCHEMBL13915177 | 0.87 | GSK3B (0.54) | GSK3BCYP2D6CYP1A2 | |
| SCHEMBL13917287 | 0.87 | GSK3B (0.57) | GSK3BCYP2D6CYP1A2CSNK1A1GSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7504411-B2 | 2,3,6-Trisubstituted-4-pyrimidone derivatives | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-03-17 | — | — | US | disclosed |
| US-7504411-B2 | 2,3,6-Trisubstituted-4-pyrimidone derivatives | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-03-17 | — | — | US | disclosed |
| WO-2004085408-A1 | 2, 3, 6-TRISUBSTITUTED-4-PYRIMIDONE DERIVATIVES | MITSUBISHI PHARMA CORPORATION (JP) | 2004-10-07 | — | — | WO | disclosed |